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Abstract
Background: Step-down dialectical behaviour therapy (DBT) is a treatment consisting of 3 months of residential
DBT plus 6 months of outpatient DBT. The program was specifically developed for people suffering from severe
borderline personality disorder (BPD). The present study examines the effectiveness and cost-effectiveness of step-
down DBT compared to 12 months of regular, outpatient DBT.
Methods: Eighty-four participants reporting high levels of BPD-symptoms (mean age 26 years, 95% female) were
randomly assigned to step-down versus standard DBT. Measurements were conducted at baseline and after 3, 6, 9
and 12 months. The Lifetime Parasuicide Count and BPD Severity Index (BPDSI) were used to assess suicidal behaviour,
non-suicidal self-injury (NSSI) and borderline severity. Costs per Quality Adjusted Life Year (QALY) were calculated using
data from the EQ-5D-3L and the Treatment Inventory Cost in Psychiatric Patients (TIC-P).
Results: In step-down DBT, 95% of patients started the program, compared to 45% of patients in outpatient DBT. The
probability of suicidal behaviour did not change significantly over 12 months. The probability of NSSI decreased
significantly in step-down DBT, but not in outpatient DBT. BPDSI decreased significantly in both groups, with the
improvement leveling off at the end of treatment. While step-down DBT was more effective in increasing quality
of life, it also cost significantly more. The extra costs per gained QALY exceeded the €80,000 threshold that is
considered acceptable for severely ill patients in the Netherlands.
Conclusions: A pragmatic randomized controlled trial in the Netherlands showed that 9 months of step-down
DBT is an effective treatment for people suffering from severe levels of BPD. However, step-down DBT is not
more effective than 12 months of outpatient DBT, nor is it more cost-effective. These findings should be considered
tentative because of high noncompliance with the treatment assignment in outpatient DBT. Furthermore, the long-
term effectiveness of step-down DBT, and moderators of treatment response, remain to be evaluated.
Trial registration: www.clinicaltrials.govNCT01904227. Registered 22 July 2013 (retrospectively registered).
Keywords: Borderline personality disorder, Dialectical behaviour therapy, Residential treatment, Suicide, Self-injurious
behaviour, Randomized controlled trial, Cost effectiveness
* Correspondence: roland.sinnaeve@kuleuven.be
†Roland Sinnaeve and Louisa M. C. van den Bosch contributed equally to this work.
1GGZ Rivierduinen - Centre for Personality Disorders Jelgersma,
Rhijngeesterstraatweg 13-C, 2342 AN Oegstgeest, The Netherlands
3Z.org KU Leuven, University of Leuven, Leuvensesteenweg 517, 3070
Kortenberg, Belgium
Full list of author information is available at the end of the article
© The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sinnaeve et al. Borderline Personality Disorder and Emotion Dysregulation
 (2018) 5:12 
https://doi.org/10.1186/s40479-018-0089-5
Background
Outpatient dialectical behaviour therapy: an efficacious
treatment for BPD
Borderline Personality Disorder (BPD) is a severe and
persistent mental disorder. Clinical hallmarks include
emotional dysregulation, impulsivity, self-injury and
chronic suicidal ideation [1]. The suicide rate is higher
than that found in the general population [2]. A recent
prospective study of the course and outcome of 290
inpatients diagnosed with BPD found a completed suicide
rate of about 4% in the first 6 years of follow-up [3]. The
diagnoses is associated with high burden of illness [4],
poor social outcome [5, 6] and health provider stigma [7].
Dialectical Behaviour Therapy (DBT) was developed for
chronically suicidal individuals diagnosed with BPD. The
treatment strategies are rooted in Linehan’s emotion regu-
lation (skills deficit) model, which states that dysfunctional
behaviour in BPD can be explained as either consequences
of pervasive emotion dysregulation or ways of coping with
it [8, 9]. The first phase of DBT focusses on skills to stop
the vicious circle of emotion dysregulation. Standard
phase one DBT has five components. First, a weekly skills
training to increase capabilities to be mindful, regulate
emotions, tolerate frustration and be effective in interper-
sonal relationships. Groups complete the curriculum twice
over the course of a year, creating a 1-year training pro-
gram. Second, individual therapy to enhance motivation
and to help apply DBT skills in daily life. A third compo-
nent, telephone coaching, facilitates skills generalization
between sessions. The fourth and fifth components include
specific case management strategies and team meetings to
help therapists stay motivated and competent [8, 9].
The efficacy of standard, outpatient DBT as a treat-
ment for BPD has been demonstrated in randomized
controlled trials (RCT) in academic settings [10–17].
Follow-up data indicated treatment gains were maintained
6 to 12 months after treatment [18–20]. It was also shown
DBT remains effective when it is implemented in
non-academic settings [21–24]. A meta-analysis about the
effects of psychological treatments for BPD confirmed that
DBT is helpful in reducing inappropriate anger and
non-suicidal self-injury (NSSI) as well as in improving
general functioning [25]. Research evaluating mechanisms
of change found applying DBT skills in daily life mediates
treatment effectiveness [26, 27].
A recurring debate: inpatient and residential treatments
for BPD
DBT was originally developed in an outpatient setting
[8, 11]. Linehan argued that if the function of suicidal
behaviour is the communication of distress, the desire
for companionship or avoidance of some aversive reality
in daily life, then being hospitalized may reinforce the
suicidal behaviour and prevent patients from developing
functional coping skills to address their problems [8]. At
the same time, longitudinal studies demonstrate that
patients diagnosed with BPD are more likely to be hospi-
talized than patients diagnosed with other mental disor-
ders [28–30]. Bloom et al. argued some patients are not
sufficiently engaged in outpatient treatment and exacer-
bations of symptoms can exceed what providers can
manage in an outpatient setting [31], suggesting the
importance of effective inpatient DBT. Bloom et al. syn-
thesized findings from 11 pre-post studies on the
efficacy of inpatient DBT. Most studies reported reduc-
tions in suicidal ideation, self-injurious behaviour and
symptoms of depression and anxiety. However, caution is
needed when interpreting these findings as none of the
studies were RCT’s, few included a comparison group and
most were plagued by sample size issues [31].
Synthesis: residential treatment as a preparation for
outpatient treatment?
Bloom et al. stated that examining the effectiveness of
inpatient DBT as an intensive preparation for outpatient
DBT is the next step in developing best-practice guide-
lines [31]. Along the same lines, we wondered if it was
possible to improve the effectiveness of DBT by developing
a step-down DBT-program using 3 months of residential
DBT as an intensive orientation to 6 months of outpatient
DBT [32]. We use the term ‘residential’ instead of ‘in-
patient’ to clarify that the residence was a home-like envir-
onment where patients only stayed on weekdays [33].
Support staff were only present during office hours. The
residential setting allowed us to adapt standard DBT proto-
col: DBT skills were trained in 3 months instead of 6
months, patients were reminded about their skills every
weekday and extra program parts, aimed at practicing and
generalizing skills, were added. We hypothesized that for
individuals suffering from high levels of BPD-symptoms
this 9-month, step-down DBT program would lead to a sig-
nificantly larger decrease in suicidal behaviour, NSSI and
total level of borderline symptomatology than 12 months of
standard DBT. We also expected that step-down DBT
would lead to fewer drop-outs and would be more
cost-effective when estimated over a 12-month period [32].
To our knowledge, this is the first time that these hypoth-
eses were evaluated in a randomized controlled trial.
Methods
We conducted an RCT with a two (group) by five (time)
repeated measures parallel design, without blinding. The
sequence of randomization was concealed until interven-
tions were assigned. The protocol was in accordance to
the principles outlined in the Declaration of Helsinki,
approved by the Institutional Review Board and registered
in www.clinicaltrials.gov [32]. There are three differences
between the study protocol in Trials and this report. First,
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the name of the residential program was changed from
‘inpatient DBT’ to ‘residential DBT’. Second, our study
ended prematurely due to an unexpected close-down of
the Centre for Personality Disorders Jelgersma (CPJ).
Third, because of unforeseen waiting list issues, partici-
pants who were randomized to outpatient DBT had to
wait longer before they met their therapist.
Sample
Participants gave written informed consent. They had to
meet the DSM-IV TR criteria for BPD (identical to the
criteria in DSM-5), be 18–45 years of age, score higher
than 24 on the Borderline Severity Index-IV (BPDSI-IV)
and report at least one episode of self-injurious behav-
iour within the month before the intake. If there was no
episode of self-injurious behaviour 1 month before the
intake, then a BDSI-score of at least 30 was required to
be eligible for the study. Exclusion criteria were limited
to having a diagnosis of a chronic psychotic disorder, bi-
polar I disorder, intellectual disability, substance depend-
ence requiring detoxification, involuntary psychiatric
treatment, insufficient command of Dutch or living out-
side of travelling distance from the treatment center.
Therapists and trainers
All therapists and trainers were psychologists, psychiatrists,
nurses or social workers working at GGZ Rivierduinen
(n = 30). DBT team members completed at minimum a
3-day training in DBT and received supervision from
the senior researcher. Adherence was assessed with the
5-point DBT Expert Rating Scale (Linehan, Lockard,
Wagner & Tutek: DBT Expert Rating Scale, unpub-
lished). Treatment integrity greater than or equal to
four was considered adherent. Fifteen percent of the
sessions were assessed. Scores ranged between 3.6 and
4.1, with an average of 3.9. Both step-down DBT and
outpatient DBT contained the five components of the
treatment protocol [8, 11, 12]. The DBT-skills were
taught according to the first version of the manual [8,
12]. The only adaption was that telephone consultation
outside of the office hours was within the limitations
set by the therapist.
Treatments
The experimental treatment, step-down DBT, consisted
of 3 months of residential DBT plus 6 months of out-
patient DBT [32]. In residential DBT, support staff were
present during office hours to help the patients apply
DBT skills. Program parts were added, including: daily
mindfulness classes, daily meetings about living together
as a group, weekly drama therapy, weekly group sessions
on validation skills and chain analyses, and fortnightly net-
work training sessions together with family and friends.
Limiting residential DBT to 3 months had several
advantages, including enabling us to limit costs, make
clear to participants that the goal was preparing for out-
patient DBT and to compare our results with ‘modal in-
patient DBT’ [31, 34, 35]. Controls received 12 months of
standard, outpatient DBT, organized in three community
mental health settings of GGZ Rivierduinen [32].
Measurements
Intake interview
Participants were screened with the Vragenlijst Kenmer-
ken Persoonlijkheid [36]. Presence of Axis 1 and Axis 2
disorders was assessed with the mini-International Neuro-
psychiatric Interview [37] and the Structured Clinical
Interview for DSM Disorders [38]. These are DSM IV-TR
diagnoses. Validated, semi-structured interviews for DSM
5 diagnoses were not available in Dutch. A Dutch transla-
tion of the Lifetime Parasuicide Count (LPC) was used to
obtain detailed information about the nature, frequency
and function of self-injurious behaviour (Comtois & Line-
han: Lifetime Parasuicide Count: description and psycho-
metrics, unpublished; van den Bosch: Vragenlijst
Parasuicidaal gedrag, unpublished). The LPC makes a dis-
tinction between self-injurious behaviour with suicidal in-
tentions (LPC Sui), without suicidal intentions (LPC
NSSI) or ambivalent suicidal intentions (LPC Amb). Fre-
quency of borderline symptoms in the previous 3-month
period was assessed with the BPDSI-IV [39].
Repeated assessments
After randomization, assessments took place at baseline
and after 3, 6, 9 and 12 months. The LPC and BPDSI
were used to collect data on suicidal behaviour, NSSI
and borderline severity in the past 3 months. Quality of
life was assessed with the EQ-5D 3 level version
(EQ-5D-3L). The health descriptions of this measure
can be linked directly to empirical valuations of the gen-
eral public, which allows utilities to be computed [40].
The Dutch tariff was used to calculate preferences for
EQ-5D health states [41]. Direct medical costs and prod-
uctivity costs were measured with the Treatment Inven-
tory Cost in Psychiatric Patients [TiC-P] [42]. Unit costs
were valued according to prices reported in the Dutch
manual for cost research [43].
Randomization
A computer program, developed by the Amsterdam Med-
ical Centre, generated the sequence. To increase the likeli-
hood of comparable treatment groups, a minimization
method was used. Minimization variables were BPDSI
score ≥ 40, total lifetime LPC score ≥ 14 and age.
Statistical analyses
Comparisons of key demographic and clinical character-
istics of the analyzed sample were performed with t-tests
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for normally distributed variables and with Wilcoxon
two sample tests for variables that were not normally
distributed. To examine the association between categor-
ical variables, we used Chi-square tests and Fisher’s
exact tests. In the repeated measurements analyses data
from the LPC, subscales were dichotomized because
they were right-skewed with excess zeros. A generalized
linear mixed model (GLMM) with random intercepts
with logistic link function was estimated for dichotom-
ous outcome variables [44]. This allowed us to examine
whether the probability (yes or no) of self-destructive
behaviour changed over time. A linear mixed model
(LMM) with random intercepts and slopes was estimated
for the BPDSI total score. In these models, condition,
time, and time x condition were included as fixed effects.
Time was expressed as number of months passed since
baseline. Model selection and inference were based on
Likelihood Ratio and Wald tests [45]. The Kaplan-Meier
statistic was used to examine whether the time to dropout
was longer for patients in step-down DBT compared
to outpatient DBT. Non-starters were excluded from
this analysis.
The cost-effectiveness of step-down DBT was assessed
by estimating an incremental cost-effectiveness ratio
(ICER). In this case, the ICER was the difference in costs
of both interventions divided by the difference in quality
adjusted life years gained (QALY’s). QALY’s were esti-
mated using the EQ-5D-3L scores. Details of procedures
to calculate the direct medical costs, productivity costs
(e.g. absenteeism and presenteeism) and the ICER can
be found in the guidelines of costing studies [43]. Subse-
quently, we assessed the probability that step-down DBT
is more effective than outpatient DBT by comparing the
costs per QALY to the costs that are considered accept-
able for severely ill patients in the Netherlands (i.e. €
80,000) [46]. Non-parametric tests were conducted since
the data were not normally distributed. A bootstrap
simulation was run for 5000 iterations to estimate 95%
confidence intervals (CI) for a range of probable values
for total costs, effects and ICERs.
Results
Participant flow
A total of 187 participants were assessed for eligibility
from February 2012 to January 2014 (Fig. 1). Sixty-three
participants did not meet the inclusion criteria. After
randomization, two out of 42 participants in step-down
DBT did not start the allocated treatment and one par-
ticipant did not provide valid baseline data. Conse-
quently, 39 participants were included in the primary
analyses. In outpatient DBT, 23 out of 42 participants
did not start the allocated treatment. This could be par-
tially due to the fact that waiting times appeared to be
longer in outpatient DBT. One participant died by sui-
cide before he received outpatient DBT. Three out of 19
Fig. 1 CONSORT flowchart pragmatic RCT step-down versus outpatient DBT. ‘Received the allocated intervention’ = Number of participants that
attended at least one skills training or at least one individual therapy session after they signed a therapist-client agreement (referred to as ‘starters’ in
the text). ‘Lost to follow up’= Number of participants that received the allocated intervention but did not complete a 12 month assessment.
‘Discontinued intervention’ = Number of participants that received the allocated intervention but dropped out before it was completely finished. In
DBT, ‘dropout’ means that a participant missed four individual therapy or four weekly skills training session in a row. ‘Analyzed’ =Number of
participants whose data were used to estimate statistical models for primary outcome variables
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participants that started outpatient DBT did not provide
valid baseline data.
Characteristics analysed sample
The sample was 95% female. Fourteen participants were
working (26%). An equal number was enrolled in col-
lege. Nineteen participants (35%) were considered unfit
for work. The majority (N = 47, 85.5%) was divorced or
single. Almost one third of the sample reported a history
of sexual abuse (N = 16, 29%) and more than half experi-
enced physical abuse (N = 30, 55%). One out of three
participants suffered from posttraumatic stress disorder
(N = 17, 31%), half were diagnosed with major depres-
sion (N = 28, 51%), and one out of three participants ful-
filled criteria of substance dependence (N = 17, 31%).
The average EQ-5D-3L score at baseline was .47 [stand-
ard deviation (SD) = .29], confirming an overall low qual-
ity of life. The total direct medical costs in the year
before the study were high. The main cost drivers were
admissions to psychiatric hospitals [€16,248 (SD =
€32,838)] and psychotherapy [€5274 (SD = €7662)].
Other characteristics can be found in Table 1. There
were no significant between-group differences in key
demographic or clinical variables.
Outcomes
Suicidal behaviour and NSSI
No completed suicides were recorded after participants
started DBT. The probability of self-injurious behaviour
with suicidal intention (LPC Sui), F(2, 156) = 2.90, p
= .06, and with ambivalent suicidal intention (LPC
Amb), F(2,156) = 2.63, p = .08, did not change signifi-
cantly over 12 months. We found that the probability of
self-injurious behaviour with suicidal intention, odds ra-
tio (OR) = .33, 95% CI [.17–.63], F(1,32) = 12.28, p = .001,
and with ambivalent suicidal intention, OR = .55, 95% CI
[.38–.81], F(1, 32) = 10.00, p = .003, decreased during the
3 months of residential treatment in the step-down DBT
group. This means that the hypothesis that a residential
setting reinforces suicidal behaviour was rejected.
There were significant changes in the probability of
NSSI (LPC NSSI) during treatment, F(2, 156) = 4.27,
p = .02. More specifically, the probability of NSSI
decreased significantly over 12 months in step-down
DBT, OR = .90, 95% CI [.82–.98], t (156) = − 2.45, p = .02,
but not in outpatient DBT, OR = .90, 95% CI [.79–1.03],
t(156) = − 1.60, p = .11. Note that the difference between
both groups is small. The fact that the OR is not
significant in the outpatient DBT may be due to its
smaller sample size. The estimated probabilities of
self-injurious episodes during step-down DBT and out-
patient DBT can be found in Table 2. The mean
frequency of self-injurious episodes can be found in
Table 3.
Drop-out
In step-down DBT, 53% of the participants who started
DBT finished the entire 9-month program. Twelve
months of outpatient DBT showed a retention rate of
63%. The results of the Kaplan Meier statistic indicated
that there were no significant differences in the time to
drop-out between conditions, Χ2(1) = .36, p = .55.
Severity of BPD
The BPDSI total–score indicated that borderline symp-
tomatology decreased significantly in both treatment
groups, F(1, 109) = 33.63, p < .0001. The regression
coefficients for months in step-down DBT and out-
patient DBT were respectively − 2.87 (SE = .37), t(109)
= − 7.86, p < .001, and − 2.82 (SE = .41), t(109) = − 6.82,
p < .0001 (Table 4). This decrease levelled off near the
end of treatment, F(1, 109) = 23.92, p < .0001. The re-
gression coefficient of the quadratic effect of months
was .1 (SE = .03) (Fig. 2).
Table 1 Comparisons of key demographic and clinical characteristics in step-down DBT and outpatient DBT
Step-down DBTa Outpatient DBTb Test
Statistic
df p
M SE M SE
Age first mental health problems 11.13 .79 11.88 .67 t = −.72 49 .47
Age first contact mental health care 14.28 1.15 15.44 1.20 t = −.59 53 .56
Number of BPD criteria 7.10 .20 7.56 .30 t = −1.25 53 .22
Severity of BPD 3 m before intake 37.17 1.27 34.75 1.29 t = 1.12 53 .27
Age at time of intake 26.15 6.18d 25.63 7.45d Z = −.71e n.a. .48
Suicide attempts lifetime 4.72 6.79d 25.84 52.90d Z = −.64e n.a. .52
Ambivalent SI lifetime (N = 54) 12.50c 28.76d 33.88 77.59d Z = .41e n.a. .68
NSSI lifetime (N = 44) 525.48c 876.74d 938.07c 1644.26d Z = −.23e n.a. .82
n.a. not applicable; Comparisons performed with t-tests for normally distributed variables and with Wilcoxon two sample tests for variables that were not normally
distributed. a N = 39; b N = 16; c Patients that persisted that they could not recall lifetime occurrence of self-injurious behaviours, because it was “too high to estimate”
were removed from calculations; d Standard deviation (SD) was reported instead of standard error (SE); e Wilcoxon two sample tests
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Costs and cost-effectiveness
After 12 months, the average EQ-5D-3L score was .65
(SD = .33) in step-down DBT and .62 (SD = .28) in out-
patient DBT. In step-down DBT, healthcare costs were
higher: €19,899 (SD = 14,210) versus €12,472 (SD =
14,300). There were no differences in productivity costs,
with €906 (SD = 3462) for step-down DBT and €964 (SD
= 3633) for outpatient DBT. The ICER with imputed
values was €278,067 per QALY. The acceptability curve
showed that the intervention has a probability of 21% of
being cost-effective if the maximum threshold is €
80,000. The ICER was recomputed to gauge the effect of
the imputation process on the underlying data. The
ICER was reduced to €220,566, which is still above the
threshold. The bootstrap-data are shown in Fig. 3. The
majority of the points (59%) lie in the north-east quad-
rant of the CE-plane. This indicates that step-down DBT
is more effective in increasing quality of life, but also
more costly, than outpatient DBT.
Discussion
We conducted a pragmatic RCT to compare 9 months
of step-down DBT to 12 months of outpatient DBT in a
sample that reported severe levels of BPD. Step-down
DBT consisted of 3 months of residential plus 6 months
of outpatient DBT. Our main findings were that: a) the
probability of suicidal behaviour did not change signifi-
cantly over 12 months, b) the probability of NSSI
decreased significantly in step-down DBT, but not in
outpatient DBT, c) severity of borderline symptomatol-
ogy decreased significantly in both groups, with the im-
provement leveling off at the end of treatment, and d)
the extra costs per gained QALY in step-down DBT
exceeded the €80,000 threshold that is considered ac-
ceptable for severely ill patients in the Netherlands.
In the step-down program, 40 out of 42 (95%) patients
were willing to initiate DBT treatment. In the outpatient
program, only 19 out of 42 (45%) patients were willing
to initiate DBT treatment. The noncompliance in out-
patient DBT may have introduced confounding. We re-
ported that participants who were randomized to
outpatient DBT had to wait longer before they met their
therapist. It is possible that participants who were willing
Table 2 Probabilities and 95% confidence intervals of self-injurious episodes based on a generalized linear mixed model
Step-down DBTa Outpatient DBTb
LPC Sui LPC Amb LPC NSSI LPC Sui LPC Amb LPC NSSI
Baseline .18 .26 .80 .29 .09 .80
[.09–.33] [.15–.42] [.65–.89] [.11–.58] [.02–.29] [.56–.93]
0–3 m .17 .20 .74 .17 .11 .75
[.09–.27] [.12–.31] [.61–.84] [.07–.36] [.04–.28] [.54–.88]
3–6 m .15 .15 .67 .09 .14 .69
[.09–.25] [.09–.25] [.54–.78] [.03–.24] [.06–.29] [.49–.83]
6–9 m .13 .11 .60 .05 .17 .62
[.07–.25] [.05–.22] [.44–.74] [.01–.19] [.07–.35] [.40–.80]
9–12 m .12 .08 .52 .02 .21 .54
[.05–.27] [.03–.21] [.33–.71] [.003–.16] [.07–.47] [.28–.78]
Timeframe = 3 months before measurement; Note: LPC Sui, LPC Amb, LPC NSSI = self-injury with respectively suicidal, ambivalent, non-suicidal intentions according to
Lifetime Parasuicide Count; a Observations: N(Baseline) = 39, N(0–3 m) = 33, N(3–6 m) = 25, N(6–9 m) = 22, N(9–12 m) = 24; b Observations: N(Baseline) = 16, N(0–3 m) =
15, N(3–6 m) = 15, N(6–9 m) = 14, N(9–12 m) = 14
Table 3 Mean frequency and standard deviation of self-injurious
episodes
Step-down DBTa Outpatient DBTb
LPC Sui LPC Amb LPC NSSI LPC Sui LPC Amb LPC NSSI
M SD M SD M SD M SD M SD M SD
Baseline 1.0 2.4 1.9 4.5 36.1 54.5 1.2 2.7 1.9 4.0 41.7 23.2
0–3 m .0 .2 3.7 13.5 13.6 34.5 .1 .3 1.0 3.9 23.2 53.1
3–6 m 1.2 4.2 1.4 6.0 23.3 52.6 .1 .3 .5 1.1 15.7 30.8
6–9 m .8 3.2 1.0 2.7 17.0 29.2 .2 .6 1.3 4.5 7.3 14.3
9–12 m .2 .7 .0 .2 4.5 9.0 .5 1.9 .9 2.1 8.6 14.0
LPC Sui, LPC Amb, LPC NSSI = self-injury with respectively suicidal, ambivalent,
non-suicidal intentions according to Lifetime Parasuicide Count; M mean, SD
standard deviation; a Observations: N(Baseline) = 39, N(0–3 m) = 33, N(3–6 m) = 25,
N(6–9 m) = 22, N(9–12 m) = 24; b Observations: N(Baseline) = 16, N(0–3 m) = 15, N(3–
6 m) = 15, N(6–9 m) = 14, N(9–12 m) = 14
Table 4 Borderline Personality Disorder Symptom Index: estimated
means based on a linear mixed model
Step-down DBTa Outpatient DBTb
M SE 95% CI M SE 95% CI
Baseline 35.80 1.38 33.07–38.52 32.27 2.14 28.02–36.52
0–3 m 28.32 1.38 25.58–31.06 24.97 2.10 20.81–29.13
3–6 m 23.14 1.68 19.82–26.47 19.97 2.41 15.19–24.75
6–9 m 20.27 1.98 16.33–24.20 17.27 2.87 11.58–22.95
9–12 m 19.69 2.44 14.85–24.52 16.86 3.51 9.91–23.82
M mean, SE standard error, CI confidence interval; a Observations: N(Baseline) =
39, N(0–3 m) = 33, N(3–6 m) = 25, N(6–9 m) = 22, N(9–12 m) = 24; b Observations:
N(Baseline) = 16, N(0–3 m) = 15, N(3–6 m) = 15, N(6–9 m) = 14, N(9–12 m) = 14
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to wait, differed systematically from those who refrained
from treatment or sought help elsewhere. Alternatively,
it is plausible that step-down DBT reached a subsample
that was unable to engage in an outpatient treatment
[31]. However, we found no significant differences on
key demographic or clinical variables between the
starters in step-down DBT and outpatient DBT. On bal-
ance, the fact that initial randomization was under-
mined, poses a threat to the internal validity of our
study. This means that the main findings should be con-
sidered tentative. In other words, the results of our study
do not warrant shifting resources from step-down to
outpatient DBT programs.
We also tested the hypothesis that a residential setting
reinforces suicidal behaviour. This hypothesis was
rejected. On the contrary, we found a significant de-
crease in the probability of suicidal behaviour during the
first 3 months of step-down DBT (i.e. the residential
phase). These findings are similar to those reported in
studies of 3-month inpatient DBT [34, 47], and challenge
the perspective that hospitalization always reinforces
suicidal behaviour in people diagnosed with BPD. It seems
that possible iatrogenic effects of hospitalization can be
neutralized if the support staff is trained in DBT. Of note,
only 35% of participants still engaged in NSSI after
Bohus’ inpatient DBT-program [34]. In our residential
DBT-program over 70% of the participants reported
that they still engaged in NSSI during treatment. Per-
centages at baseline were almost identical: about 75%
[34, 47]. This difference may be related to the time-
frame that was used to measure NSSI. In Bohus et al.,
participants were asked to report NSSI that occurred in
the last month. In our study, participants were asked to
report NSSI that occurred in the last 3 months. An-
other plausible explanation is the difference in coaching
after office hours. The hospital setting in Bohus et al.
allowed for 24/7 crisis interventions by support staff. In
our study, support staff were only present during office
Fig. 2 Estimated Borderline Personality Symptom Index score with time, condition and time x condition as predictors
Fig. 3 Cost-effectiveness plane step-down DBT versus outpatient DBT. The Y-axis represents additional effects. The X-axis represents additional costs
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hours and on weekdays. Telephone consultation after
office hours was within the limitations set by the ther-
apist. Future research should take this into account, ei-
ther by implementing this component of DBT as well,
or by conducting a dismantling study first.
Some strengths of the present study are notable. First,
we ensured that interventions were allocated by means
of a concealed randomization procedure. Second, treat-
ment adherence was evaluated in both conditions. Third,
the protocol was published in advance and all analyses
were performed by independent experts [32]. Fourth,
our design has strong ecological validity given that it
was performed in a nonacademic context. On the other
hand, this project had several limitations. Foremost, the
initial randomization was undermined by a high percent-
age of non-starters in outpatient DBT. Second, data
collectors were not blind to the assigned intervention.
Third, the skills training groups of outpatient DBT con-
tained patients that did not participate in the study.
Thus, the composition of the skills training groups in out-
patient DBT differed from the groups in step-down DBT,
which consisted only of study participants. Fourth, evalu-
ation of treatment integrity showed that some sessions
were non-adherent (DBT Expert Rating Scale scores <
4.0). A final limitation is the lack of follow-up data.
The effectiveness of step-down versus outpatient DBT
for patients that report severe levels of BPD-symptoms re-
mains to be established in future research. It will be
equally important to assess which moderators (e.g. charac-
teristics of the individual or his/her social context, treat-
ment integrity, regional differences in mental health care
organization and stigma) change the direction or strength
of the relation between the treatment (step-down versus
outpatient) and the outcome (e.g. NSSI, BPDSI, drop-out,
QALY). Given the treatment outcomes we reported in this
pragmatic RCT, treatment integrity, in particular, deserves
further examination. Adherence to a protocol is essential
for internal validity and generalizability of the results in
our domain of research. However, it would be interesting to
learn more about the relationship between treatment ad-
herence and treatment outcome. Is it a linear relationship?
Or does the added value lessen once a certain level of ad-
herence is reached? Finally, yet importantly: the long-term
effectiveness and cost-effectiveness of step-down DBT re-
main to be evaluated.
The main methodological challenges we encountered
were noncompliance and attrition in outpatient DBT. We
do not know whether these phenomena indicate that
step-down DBT was more effective at engaging people
suffering from severe levels of BPD [31]. To answer this
question in future research, we need to rule out waiting
list issues and strengthen participants’ commitment before
randomization takes place. When these conditions are
met, higher compliance in step-down DBT would provide
support for Bloom’s hypothesis [31]. A second step would
be to find out what predicts compliance in step-down and
in outpatient DBT. We found no significant differences in
demographic or clinical variables in our study. Perhaps
factors that we did not include, such as social isolation,
institutionalization, and marginalization, were paramount.
A last consideration is that, even though interesting in its
own right, noncompliance challenges the feasibility and
validity of a RCT. We would suggest future researchers to
consider a Zelen’s design, or to add a second control con-
dition that would allow us to compare step-down DBT to
‘residential care as usual’ plus outpatient DBT [48].
Conclusions
A pragmatic randomized controlled trial in the Netherlands
showed that 9 months of step-down DBT is an effective
treatment for people suffering from severe levels of BPD.
However, step-down DBT was not more effective than 12
months of outpatient DBT, nor was it more cost-effective.
These findings should be considered tentative because of
relatively high noncompliance with the treatment assign-
ment in outpatient DBT. Furthermore, the long-term
effectiveness of step-down DBT, and moderators of treat-
ment response, remain to be evaluated.
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